Common drug may shield myeloma patients from chemo nerve pain
NCT ID NCT07025005
First seen Nov 06, 2025 · Last updated May 15, 2026 · Updated 19 times
Summary
This study tests whether fenofibrate, a medicine usually used for high cholesterol, can reduce nerve damage (peripheral neuropathy) caused by a common chemotherapy combination for multiple myeloma. About 44 newly diagnosed patients will receive either standard chemo alone or chemo plus fenofibrate. Researchers will track nerve symptoms and blood markers to see if fenofibrate offers protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Damanhur Oncology Center
RECRUITINGDamanhur, El- Behira, Egypt
-
Tanta University
RECRUITINGTanta, El-Gharbya, Egypt
Conditions
Explore the condition pages connected to this study.